CA1136620A
(en)
|
1979-01-08 |
1982-11-30 |
Ulf P.F. Lindahl |
Heparin fragments having selective anticoagulation activity
|
FR2614026B1
(fr)
|
1987-04-16 |
1992-04-17 |
Sanofi Sa |
Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
|
DE68906345T2
(de)
*
|
1988-10-07 |
1993-10-28 |
Hoechst Ag |
Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
|
SE9002550D0
(sv)
|
1990-08-01 |
1990-08-01 |
Kabivitrum Ab |
Heparinfragment
|
SE9003181D0
(sv)
|
1990-10-04 |
1990-10-04 |
Kabivitrum Ab |
Use of heparin fraction
|
US5280016A
(en)
|
1991-03-29 |
1994-01-18 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
US5250519A
(en)
*
|
1991-03-29 |
1993-10-05 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
JPH0532703A
(ja)
*
|
1991-07-26 |
1993-02-09 |
Terumo Corp |
低分子量ヘパリン誘導体の製造法
|
WO1994008595A1
(en)
|
1992-10-13 |
1994-04-28 |
Virginia Commonwealth University |
Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
|
US5527785A
(en)
*
|
1993-05-14 |
1996-06-18 |
The Regents Of The University Of California |
Selectin receptor modulating compositions
|
GB2299998B
(en)
*
|
1995-03-31 |
1997-03-26 |
Hamilton Civic Hospitals Res |
Compositions for inhibiting thrombogenesis
|
US5993810A
(en)
|
1996-03-15 |
1999-11-30 |
Lebovitz; Shamir Israel |
Method of softening or ripening the cervix of a female mammal using collagenase
|
US5767269A
(en)
|
1996-10-01 |
1998-06-16 |
Hamilton Civic Hospitals Research Development Inc. |
Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
|
WO1998016559A1
(fr)
|
1996-10-15 |
1998-04-23 |
Toray Industries, Inc. |
Agent de maturation des canaux cervicaux
|
GB9711443D0
(en)
|
1997-06-03 |
1997-07-30 |
Leo Pharm Prod Ltd |
Chemical suppositions
|
JP3342007B2
(ja)
*
|
1997-11-20 |
2002-11-05 |
郁男 山科 |
低分子ヘパリン修飾体及び皮膚潰瘍治療剤
|
US6596705B1
(en)
*
|
1998-02-09 |
2003-07-22 |
The Regents Of The University Of California |
Inhibition of L-selectin and P-selection mediated binding using heparin
|
EP1059304B1
(en)
|
1998-02-26 |
2006-04-26 |
Seikagaku Corporation |
Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
|
US6028061A
(en)
*
|
1998-06-18 |
2000-02-22 |
Children's Medical Center Corp |
Angiogenesis inhibitors and use thereof
|
WO2000006608A1
(fr)
*
|
1998-07-31 |
2000-02-10 |
Seikagaku Corporation |
Nouveau glycosaminoglycan et compositions medicamenteuses le contenant
|
BR0012202A
(pt)
*
|
1999-06-30 |
2002-04-02 |
Hamilton Civic Hospitals Res |
Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh
|
JP4897991B2
(ja)
*
|
1999-07-23 |
2012-03-14 |
ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ |
超低分子量ヘパリン組成物
|
IT1316986B1
(it)
|
2000-01-25 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
|
JP4585072B2
(ja)
*
|
2000-02-29 |
2010-11-24 |
扶桑薬品工業株式会社 |
ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
|
ES2324701T3
(es)
*
|
2000-09-12 |
2009-08-13 |
Massachusetts Institute Of Technology |
Metodos y productos relacionados con heparina de peso molecular bajo.
|
SE521676C2
(sv)
|
2002-01-02 |
2003-11-25 |
Dilafor Ab |
Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
|
US20040072796A1
(en)
|
2002-04-18 |
2004-04-15 |
Embury Stephen H. |
Method and composition for preventing pain in sickle cell patients
|
US8071569B2
(en)
|
2002-09-20 |
2011-12-06 |
Mousa Shaker A |
Oxidized heparin fractions and their use in inhibiting angiogenesis
|
EP1582531A1
(en)
|
2004-03-24 |
2005-10-05 |
Aventis Pharma S.A. |
Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
|
WO2005107713A2
(en)
*
|
2004-05-11 |
2005-11-17 |
Egalet A/S |
Swellable dosage form comprising gellan gum
|
US20060040896A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Paringenix, Inc. |
Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
|
US7741311B2
(en)
*
|
2005-01-03 |
2010-06-22 |
Shaker Mousa |
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
|
US20080214480A1
(en)
*
|
2005-07-22 |
2008-09-04 |
Trf Pharma, Inc. |
Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
|
MX2008000974A
(es)
*
|
2005-07-22 |
2008-03-27 |
Univ California |
Composiciones de heparina e inhibicion de selectina.
|
AU2007267561B2
(en)
*
|
2006-05-25 |
2012-05-17 |
Momenta Pharmaceuticals, Inc. |
Low molecular weight heparin composition and uses thereof
|
WO2009007224A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Low molecular weight heparin derivatives having neuroprotective activity
|
US8592393B2
(en)
*
|
2007-11-02 |
2013-11-26 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
US8569262B2
(en)
*
|
2007-11-02 |
2013-10-29 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
EP2205642B1
(en)
*
|
2007-11-02 |
2016-01-27 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
WO2009073184A1
(en)
|
2007-12-03 |
2009-06-11 |
Florida State University Research Foundation, Inc. |
Compositions for inducing labor and associated methods
|
BRPI0909849A2
(pt)
*
|
2008-04-04 |
2015-10-06 |
Univ Utah Res Found |
éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
|
CN102105427A
(zh)
*
|
2008-07-25 |
2011-06-22 |
阿尔法制药有限公司 |
粒度直径范围(D90)为大于3μm至约10μm的阿托伐醌
|
JP5721274B2
(ja)
*
|
2009-04-16 |
2015-05-20 |
モメンタ ファーマシューティカルズ インコーポレイテッド |
多糖組成物の活性を評価する方法
|
US20120108538A1
(en)
*
|
2009-06-30 |
2012-05-03 |
James Beeson |
Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
|
US9475888B2
(en)
|
2011-12-19 |
2016-10-25 |
Dilafor Ab |
Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
|
WO2013095215A1
(en)
|
2011-12-19 |
2013-06-27 |
Dilaforette Ab |
Low anticoagulant heparins
|
MX2014011451A
(es)
|
2012-03-26 |
2014-11-10 |
Dilafor Ab |
Procedimiento de tratamiento de la interrupcion del parto.
|
SG11201406119WA
(en)
|
2012-03-26 |
2014-11-27 |
Dilafor Ab |
Combination treatment comprising sulphated glycosaminoglycans for inducing labor
|